A report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals reveals, that cerebrospinal fluid levels of Aβ42 seem to be decreased at least five to 10 years prior to some patients with mild cognitive impairment developing Alzheimer disease (AD) dementia, whilst other spinal fluid levels seem to be later markers of disease...